These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

448 related articles for article (PubMed ID: 19395241)

  • 1. Effects and side effects of antipsychotic treatment in schizophrenia: pros and cons of available self-rating scales.
    Wolters HA; Knegtering H; van den Bosch RJ; Wiersma D
    Schizophr Res; 2009 Jul; 112(1-3):114-8. PubMed ID: 19395241
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Subjective well-being in schizophrenia as measured with the Subjective Well-Being under Neuroleptic Treatment scale: a review.
    Vothknecht S; Schoevers RA; de Haan L
    Aust N Z J Psychiatry; 2011 Mar; 45(3):182-92. PubMed ID: 21438745
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Psychometric evaluation of the Subjective Well-being Under Neuroleptic Treatment Scale (SWN) in patients with schizophrenia, their relatives and controls.
    Vothknecht S; Meijer C; Zwinderman A; Kikkert M; Dekker J; van Beveren N; Schoevers R; de Haan L;
    Psychiatry Res; 2013 Mar; 206(1):62-7. PubMed ID: 23021423
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Psychometric evaluation of the Medication Satisfaction Questionnaire (MSQ) to assess satisfaction with antipsychotic medication among schizophrenia patients.
    Vernon MK; Revicki DA; Awad AG; Dirani R; Panish J; Canuso CM; Grinspan A; Mannix S; Kalali AH
    Schizophr Res; 2010 May; 118(1-3):271-8. PubMed ID: 20172695
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The effect of paliperidone extended release on subjective well-being and responses in patients with schizophrenia.
    Kim SW; Yoon JS; Kim YS; Ahn YM; Kim CE; Go HJ; Chee IS; Jung SW; Chung YC; Kim YD; Joe S; Lee J; Kwon YJ; Yoon BH; Jae YM
    Prog Neuropsychopharmacol Biol Psychiatry; 2012 Aug; 38(2):228-35. PubMed ID: 22516251
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Correlation of subjective well-being in schizophrenic patients with gait parameters, expert-rated motor disturbances, and psychopathological status.
    Putzhammer A; Perfahl M; Pfeiff L; Hajak G
    Pharmacopsychiatry; 2005 May; 38(3):132-8. PubMed ID: 15902585
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Quality of life and subjective well-being during treatment with antipsychotics in out-patients with schizophrenia.
    Wehmeier PM; Kluge M; Schneider E; Schacht A; Wagner T; Schreiber W
    Prog Neuropsychopharmacol Biol Psychiatry; 2007 Apr; 31(3):703-12. PubMed ID: 17289237
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Quality of life in schizophrenia: the impact of psychopathology, attitude toward medication, and side effects.
    Hofer A; Kemmler G; Eder U; Edlinger M; Hummer M; Fleischhacker WW
    J Clin Psychiatry; 2004 Jul; 65(7):932-9. PubMed ID: 15291682
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Validation of the Spanish version of the Subjective Well-being under Neuroleptic Scale (SWN-K) in patients with schizophrenia].
    Sanjúan J; Haro JM; Mauriño J; Díez T; Ballesteros J
    Med Clin (Barc); 2012 Feb; 138(4):151-4. PubMed ID: 21571347
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Psychometric properties of the Subjective Well-Being Under Neuroleptics scale and the Subjective Deficit Syndrome Scale.
    de Haan L; Weisfelt M; Dingemans PM; Linszen DH; Wouters L
    Psychopharmacology (Berl); 2002 Jun; 162(1):24-8. PubMed ID: 12107613
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Intercultural differences in factor structure of the SWN-20 in patients with schizophrenia.
    Hwang SS; Kim EY; Kim SH; Kim YS; Ahn YM
    Compr Psychiatry; 2013 Oct; 54(7):970-3. PubMed ID: 23763873
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Fewer symptoms vs. more side-effects in schizophrenia? Opposing pathways between antipsychotic medication compliance and quality of life.
    Staring AB; Mulder CL; Duivenvoorden HJ; De Haan L; Van der Gaag M
    Schizophr Res; 2009 Aug; 113(1):27-33. PubMed ID: 19525092
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Subjective well-being, drug attitude, and changes in symptomatology in chronic schizophrenia patients starting treatment with new-generation antipsychotic medication.
    Widschwendter CG; Kemmler G; Rettenbacher MA; Yalcin-Siedentopf N; Hofer A
    BMC Psychiatry; 2018 Jun; 18(1):212. PubMed ID: 29954366
    [TBL] [Abstract][Full Text] [Related]  

  • 14. DAI-10 is as good as DAI-30 in schizophrenia.
    Nielsen RE; Lindström E; Nielsen J; Levander S
    Eur Neuropsychopharmacol; 2012 Oct; 22(10):747-50. PubMed ID: 22440974
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Evaluation of subjective treatment satisfaction with antipsychotics in schizophrenia patients.
    Fujikawa M; Togo T; Yoshimi A; Fujita J; Nomoto M; Kamijo A; Amagai T; Uchikado H; Katsuse O; Hosojima H; Sakura Y; Furusho R; Suda A; Yamaguchi T; Hori T; Kamada A; Kondo T; Ito M; Odawara T; Hirayasu Y
    Prog Neuropsychopharmacol Biol Psychiatry; 2008 Apr; 32(3):755-60. PubMed ID: 18226436
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Subjective side effects of antipsychotics and medication adherence in people with schizophrenia.
    McCann TV; Clark E; Lu S
    J Adv Nurs; 2009 Mar; 65(3):534-43. PubMed ID: 19222651
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Evaluating subjective domains of antipsychotic-induced adverse effects using heart rate variability.
    Chang JS; Hwang SS; Yi SH; Kim Y; Lee YS; Kim YS; Jung HY
    Psychiatry Clin Neurosci; 2015 May; 69(5):283-91. PubMed ID: 25066617
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Patient-rated versus clinician-rated side effects of drug treatment in schizophrenia. Clinical validation of a self-rating version of the UKU Side Effect Rating Scale (UKU-SERS-Pat).
    Lindström E; Lewander T; Malm U; Malt UF; Lublin H; Ahlfors UG
    Nord J Psychiatry; 2001; 55 Suppl 44():5-69. PubMed ID: 11860666
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Subjective response to neuroleptics: the effect of a questionnaire about neuroleptic side effects.
    Taira M; Hashimoto T; Takamatsu T; Maeda K
    Prog Neuropsychopharmacol Biol Psychiatry; 2006 Aug; 30(6):1139-42. PubMed ID: 16765499
    [TBL] [Abstract][Full Text] [Related]  

  • 20. A self-rating to measure subjective effects of neuroleptic drugs, relationships to objective psychopathology, quality of life, compliance and other clinical variables.
    Naber D
    Int Clin Psychopharmacol; 1995 Sep; 10 Suppl 3():133-8. PubMed ID: 8866775
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 23.